April 2023
Ambrose N et al. Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes. JAMA Netw Open. 2023;6(4):e239694. doi:10.1001/jamanetworkopen.2023.9694
Full text
Áñez G et al. Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(4):e239135. doi:10.1001/jamanetworkopen.2023.9135
Full text
Chang L et al. Changes in Brain Activation Pattern During Working Memory Tasks in People With Post-COVID Condition and Persistent Neuropsychiatric Symptoms. Neurology. 2023 Apr 10.1212/WNL.0000000000207309; DOI: 10.1212/WNL.0000000000207309
Full text
Chaichana U et al. Definition of Post–COVID-19 Condition Among Published Research Studies. JAMA Netw Open. 2023;6(4):e235856. doi:10.1001/jamanetworkopen.2023.5856
Full text
Cini C et al. Inter-hospital transfer and clinical outcomes for people with COVID-19 admitted to intensive care units in Australia: an observational cohort study. Med J Aust. 2023 Apr 10. doi: 10.5694/mja2.51917. Epub ahead of print. PMID: 37037671.
Full text
DeSilva MB et al. Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022. J Infect Dis. 2023 Apr 18;227(8):961-969. doi: 10.1093/infdis/jiac458. PMID: 36415904.
Full text
Dorney I et al. Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data. JAMA Ophthalmol. 2023 Apr 13:e230610. doi: 10.1001/jamaophthalmol.2023.0610. Epub ahead of print. PMID: 37052897; PMCID: PMC10102921.
Full text
European Society of Microbiology and Infectious Diseases. Omicron appears more deadly than seasonal influenza, study suggests. EurekAlert News Reslease. 2023 Apr 6.
Full text
Fortin A et al. (2023). Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19. Clinical Microbiology and Infection. doi.org/10.1016/j.cmi.2023.03.019.
Full text
Firestein MR et al. Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy. JAMA Netw Open. 2023;6(4):e237396. doi:10.1001/jamanetworkopen.2023.7396
Full text
Fung KW et al. Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US. PLoS Med. 2023 Apr 17;20(4):e1004194. doi: 10.1371/journal.pmed.1004194. Epub ahead of print. PMID: 37068113.
Full text
Gao L et al. Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial. Lancet Child Adolesc Health. 2023 Apr;7(4):269-279. doi: 10.1016/S2352-4642(22)00376-5. Epub 2023 Feb 17. PMID: 36803632; PMCID: PMC9937662.
Full text
Hesse E M et al. COVID-19 Vaccine Safety First Year Findings in Adolescents. Pediatrics. 2023 Apr 21. https://doi.org/10.1542/peds.2022-060295
Full text
Jackson C et al. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. The Lancet Resp Med. 2023 Apr 15. DOI:https://doi.org/10.1016/S2213-2600(23)00124-8
Full text
Kip K E et al. Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19. Annals of Int Med. 2023 Apr. https://doi.org/10.7326/M22-1286
Full text
Li et al. mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia. Vaccine. 2023 Apr doi: https://doi.org/10.1016/j.vaccine.2023.01.075.
Full text
Lim Y et al. Association of Physical Activity With SARS-CoV-2 Infection and Severe Clinical Outcomes Among Patients in South Korea. JAMA Netw Open. 2023;6(4):e239840. doi:10.1001/jamanetworkopen.2023.9840
Full text
Liu, W.J et al. Surveillance of SARS-CoV-2 at the Huanan Seafood Market. Nature (2023). https://doi.org/10.1038/s41586-023-06043-2
Full text
McMaster C et al. COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort. Rheumatology (Oxford). 2023 Apr 3;62(4):1460-1466. doi: 10.1093/rheumatology/keac503. PMID: 36069664; PMCID: PMC9494403.
Full text
Mitchell R et al. Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022. JAMA Netw Open. 2023;6(4):e239050. doi:10.1001/jamanetworkopen.2023.9050
Full text
Mourad A et al. Dexamethasone for Inpatients With COVID-19 in a National Cohort. JAMA Netw Open. 2023;6(4):e238516. doi:10.1001/jamanetworkopen.2023.8516
Full text
Pittet L et al. Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers. NEJM. 2023 Apr 27. DOI: 10.1056/NEJMoa2212616
Full text
Reis G et al. Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19. A Randomized Platform Trial. Annals of Inter Med. 2023 Apr 18. https://doi.org/10.7326/M22-3305
Full text
RECOVERY Collaborative Group. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2023 Apr 12. DOI:https://doi.org/10.1016/S0140-6736(23)00510-X
Full text
Selvakumar J et al. Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults. JAMA Netw Open. 2023;6(3):e235763. doi:10.1001/jamanetworkopen.2023.5763
Full text
Seyed Arad Moghadasi et al. Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. Sci. Adv.9,eade8778(2023).DOI:10.1126/sciadv.ade8778
Full text
Sharma, C et al. High risk of autoimmune diseases after COVID-19. Nat Rev Rheumatol (2023). https://doi.org/10.1038/s41584-023-00964-y
Full text
Spungen H et al. Completeness and Spin of medRxiv Preprint and Associated Published Abstracts of COVID-19 Randomized Clinical Trials. JAMA. 2023;329(15):1310–1312. doi:10.1001/jama.2023.1784
Full text
Tsang NNY et al. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. Lancet Infect Dis. 2023 Apr;23(4):421-434. doi: 10.1016/S1473-3099(22)00732-0. Epub 2022 Dec 12. PMID: 36521506; PMCID: PMC9744442.
Full text
Xie R et al. Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong. Nat Commun. 2023 Apr 27;14(1):2422. doi: 10.1038/s41467-023-38201-5. PMID: 37105966; PMCID: PMC10134727.
Full text
Xie Y et al. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ 2023 Apr 25; 381 doi: https://doi.org/10.1136/bmj-2022-074572
Full text
Zakia H et al. (2023) Risk factors for psychiatric symptoms in patients with long COVID: A systematic review. PLoS ONE 18(4): e0284075. https://doi.org/10.1371/journal.pone.0284075
Full text
March 2023
Alvergne A et al. A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease. iScience. 2023 Mar 15. DOI:https://doi.org/10.1016/j.isci.2023.106401
Full text
Barateaux V et al. Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination. 2023 Mar 15. Science Tranlational Medicine. 2023 Mar 15. https://doi.org/10.1126/scitranslmed.ade0550
Full text
Bramante C et al. Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 Trial. Lancet Pre-print. Available at SSRN: https://ssrn.com/abstract=4375620 or http://dx.doi.org/10.2139/ssrn.4375620
Full text
Byambasuren O et al. Effect of covid-19 vaccination on long covid: systematic review. BMJ Medicine 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385
Full text
Bennet C M. Covid-19 in Australia: How did a country that fought so hard for extra time end up so ill prepared? BMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p469
Full text
Calvert C. et al. Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries. Nat Hum Behav (2023). https://doi.org/10.1038/s41562-023-01522-y
Abstract
Cheung M W et al. Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients. medRxiv 2023.03.01.23286513; doi: https://doi.org/10.1101/2023.03.01.23286513
Full text
Deo R et al. Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection. Annals of Int Med. 2023 Mar. https://doi.org/10.7326/M22-2381
Full text
DeVries A et al. One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database. JAMA Health Forum. 2023;4(3):e230010. doi:10.1001/jamahealthforum.2023.0010
Full text
Edlow AG et al. Sex-Specific Neurodevelopmental Outcomes Among Offspring of Mothers With SARS-CoV-2 Infection During Pregnancy. JAMA Netw Open. 2023;6(3):e234415. doi:10.1001/jamanetworkopen.2023.4415
Full text
Fai E Y et al. Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19. Annals of Int Med. 2023 March 14. Doi: https://doi.org/10.7326/M22-3057
Full text
Fang MC et al. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA Netw Open. 2023;6(3):e232338. doi:10.1001/jamanetworkopen.2023.2338
Full text
Gao F et al Robust T cell responses to Pfizer/BioNTech vaccine compared to infection and evidence of attenuated peripheral CD8+ T cell responses due to COVID-19. Immunity. 2023 Mar 15. DOI:https://doi.org/10.1016/j.immuni.2023.03.005
Full text
Gilbert G L. Aged care residents — and everybody else — would benefit from better control of COVID‐19 transmission. Med J Aust 2023; 218 (4): 166-167. || doi: 10.5694/mja2.51843
Full text
Goligher EC et al. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19. JAMA. Published online March 21, 2023. doi:10.1001/jama.2023.3651
Full text
Harris E. Nasally Administered Monoclonal Antibody for COVID-19. JAMA. Published online March 22, 2023. doi:10.1001/jama.2023.4000
Full text
Heine J et al. Structural brain changes in patients with post-COVID fatigue: a prospective observational study. eClinical Med. 2023 February 27. DOI:https://doi.org/10.1016/j.eclinm.2023.101874
Full text
Jang EJ et al. Estimated Effectiveness of Prior SARS-CoV-2 BA.1 or BA.2 Infection and Booster Vaccination Against Omicron BA.5 Subvariant Infection. JAMA Netw Open. 2023;6(3):e232578. doi:10.1001/jamanetworkopen.2023.2578
Full text
Koirala A et al. Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study. The Lancet. 2023 March 22. DOI:https://doi.org/10.1016/j.lanwpc.2023.100736
Full text
Labbé V et al. Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial. JAMA Intern Med. Published online March 22, 2023. doi:10.1001/jamainternmed.2023.0456
Full text
Maia I S et al. Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trial. The Lancet. 2023 March 07. DOI:https://doi.org/10.1016/j.lana.2023.100466
Full text
McGarry B E et al. Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes. NEJM. 2023 March 23. DOI: 10.1056/NEJMoa2210063
Full text
O’Brien WJ et al. Estimated Risk of Adverse Surgical Outcomes Among Patients With Recent COVID-19 Infection Using Target Trial Emulation Methods. JAMA Netw Open. 2023;6(3):e234876. doi:10.1001/jamanetworkopen.2023.4876
Full text
Ockene MW et al. Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure, The Journal of Clinical Endocrinology & Metabolism, 2023;, dgad130, https://doi.org/10.1210/clinem/dgad130
Full text
Schweizer S et al. COVID-19 Risks Across the Lifespan (CORAL) Consortium. Association of Antenatal COVID-19–Related Stress With Postpartum Maternal Mental Health and Negative Affectivity in Infants. JAMA Netw Open. 2023;6(3):e232969. doi:10.1001/jamanetworkopen.2023.2969
Full text
Spiegel K et al. A meta-analysis of the associations between insufficient sleep duration and antibody response to vaccination. Current Biology. 2023 Mar 13. DOI:https://doi.org/10.1016/j.cub.2023.02.017
Full text
Sumner MW et al. Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada. JAMA Netw Open. 2023;6(3):e232328. doi:10.1001/jamanetworkopen.2023.2328
Full text https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2802161
Full text
Sun Y et al. Comparison of mental health symptoms before and during the covid-19 pandemic: evidence from a systematic review and meta-analysis of 134 cohorts BMJ 2023; 380 :e074224 doi:10.1136/bmj-2022-074224
Full text
Tanne J H. Covid-19: US studies show racial and ethnic disparities in long covid BMJ 2023 March 06. doi: https://doi.org/10.1136/bmj.p535
Full text
The Lancet. Long COVID: 3 years in. The Lancet. 2023 March 23. DOI:https://doi.org/10.1016/S0140-6736(23)00493-2
Full text
Tsampasian V et al. Risk Factors Associated With Post−COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. Published online March 23, 2023. doi:10.1001/jamainternmed.2023.0750
Full text
Wang Y et al. Sarcopenia and COVID-19 Outcomes. Clin Interv Aging. 2023 Mar 9;18:359-373. doi: 10.2147/CIA.S398386. PMID: 36923269; PMCID: PMC10010141.
Full text
Wang H et al. Relationship between antidepressants and severity of SARS-CoV-2 Omicron infection: a retrospective cohort study using real-world data. The Lancet. 2023 Feb 27. DOI:https://doi.org/10.1016/j.lanwpc.2023.100716
Full text
Xie Y et al. Molnupiravir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records BMJ 2023; 380 :e072705 doi:10.1136/bmj-2022-072705
Full text
Xie Y et al. Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition. JAMA Intern Med. Published online March 23, 2023. doi:10.1001/jamainternmed.2023.0743
Full text
Xu, E et al. Long-term gastrointestinal outcomes of COVID-19. Nat Commun 14, 983 (2023). https://doi.org/10.1038/s41467-023-36223-7
Full text
Zhang XJ et al. Prevalence of Myopia in Children Before, During, and After COVID-19 Restrictions in Hong Kong. JAMA Netw Open. 2023;6(3):e234080. doi:10.1001/jamanetworkopen.2023.4080
Full text
February 2023
Aggarwal N et al. Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study. The Lancet. 2023 Feb10. DOI:https://doi.org/10.1016/S1473-3099(23)00011-7
Full text
Burgess T et al. Key ethical issues encountered during COVID-19 research: a thematic analysis of perspectives from South African research ethics committees. BMC Med Ethics 24, 11 (2023). https://doi.org/10.1186/s12910-023-00888-y
Full text
Callaway E et al. COVID drug drives viral mutations — and now some want to halt its use. 2023 Feb 7. Nature 614, 399 (2023) doi: https://doi.org/10.1038/d41586-023-00347-z
Full text
Chourpiliadis C et al. (2023) Short-term improvement of mental health after a COVID-19 vaccination. PLoS ONE 18(2): e0280587. https://doi.org/10.1371/journal.pone.0280587
Full text
COVID-19 Forecasting team. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. The Lancet. 2023 Feb 16. DOI:https://doi.org/10.1016/S0140-6736(22)02465-5
Full text
Dagher H et al. (2023) Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. eLife 12:e81182. https://doi.org/10.7554/eLife.81182
Full text
Dennis A et al. Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study. Journal of the Royal Society of Medicine. 2023;0(0). doi:10.1177/01410768231154703
Full text
Dowse G et al. Born into an isolating world: family-centred care for babies born to mothers with COVID-19. eClinicalMedicine. 2023 Feb 21. DOI:https://doi.org/10.1016/j.eclinm.2022.101822
Full text
Frasca L et al. Safety of COVID-19 vaccines in patients with autoimmune diseases, in patients with cardiac issues, and in the healthy population. Pathogens. 2023; 12(2):233. https://doi.org/10.3390/pathogens12020233
Full text
Huang S et al. China's COVID-19 reopening measures—warriors and weapons. The Lancet. 2023 Feb 25. DOI:https://doi.org/10.1016/S0140-6736(23)00213-1
Full text
Huang, P et al. Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms. Transl Neurodegener 12, 5 (2023). https://doi.org/10.1186/s40035-023-00337-1
Full text
Jefferson T et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Systematic Reviews 2023, Issue 1. Art. No.: CD006207. DOI: 10.1002/14651858.CD006207.pub6. Accessed 26 February 2023.
Full text
Jorgensen S et al. Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study. BMJ 2023 Feb 8. doi: https://doi.org/10.1136/bmj-2022-074035
Full text
Kiang MV et al. Excess mortality among US physicians during the COVID-19 pandemic. JAMA Intern Med. Published online February 06, 2023. doi:10.1001/jamainternmed.2022.6308
Full text
Kwan AC et al. Association of COVID-19 vaccination with risk for incident diabetes after COVID-19 infection. JAMA Netw Open. 2023;6(2):e2255965. doi:10.1001/jamanetworkopen.2022.55965
Full text
Kwok, W.C et al. Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong. Respir Res 24, 53 (2023). https://doi.org/10.1186/s12931-023-02363-z
Full text
Lai CC et al. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J Microbiol Immunol Infect. 2023 Feb;56(1):1-9. doi: 10.1016/j.jmii.2022.10.003. Epub 2022 Oct 15. PMID: 36283919; PMCID: PMC9576029.
Full text
Lai F et al. Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study. CMAJ Jan 2023, 195 (4) E143-E152; DOI: 10.1503/cmaj.221068
Full text
Langford B et al. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. The Lancet Micobiome. 2023 Jan 31. DOI:https://doi.org/10.1016/S2666-5247(22)00355-X
Full text
Morawska L et al. COVID-19 and airborne transmission: Science rejected, lives lost. Can society do better?, Clinical Infectious Diseases, 2023;, ciad068, https://doi.org/10.1093/cid/ciad068
Full text
Munoz FM et al. Evaluation of BNT162b2 Covid-19 vaccine in children younger than 5 years of age. N Engl J Med 2023; 388:621-634 DOI: 10.1056/NEJMoa2211031
Full text
Murakami M et al Sensitivity of rapid antigen tests for COVID-19 during the Omicron variant outbreak among players and staff members of the Japan Professional Football League and clubs: a retrospective observational study. BMJ Open 2023;13:e067591. doi: 10.1136/bmjopen-2022-067591
Full text
Naggie S et al. Effect of higher-dose ivermectin for 6 Days vs placebo on time to sustained recovery in outpatients with COVID-19: A randomized clinical trial. JAMA. Published online February 20, 2023. doi:10.1001/jama.2023.1650
Full text
Pan Y et al. Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis. The Lancet. 2023 Feb 8. DOI:https://doi.org/10.1016/S0140-6736(23)00129-0
Full text
Portmann L et al. Hospital outcomes of community-acquired SARS-CoV-2 omicron variant infection compared with influenza infection in Switzerland. JAMA Netw Open. 2023;6(2):e2255599. doi:10.1001/jamanetworkopen.2022.55599
Full text
Raw RK et al. (2023) Increased adverse events following third dose of BNT162b2/Pfizer vaccine in those with previous COVID-19, but not with concurrent influenza vaccine. PLOS Glob Public Health 3(2): e0001053. https://doi.org/10.1371/journal.pgph.0001053
Full text
Reis G et al. Early treatment with pegylated interferon lambda for Covid-19. NEJM. 2023 Feb 9. DOI: 10.1056/NEJMoa2209760.
Full text
Sanderson T et al. Identification of a molnupiravir-associated mutational signature in SARS-CoV-2 sequencing databases. medRxiv 2023.01.26.23284998; doi: https://doi.org/10.1101/2023.01.26.23284998
Full text
Sicouri G et al. Mental health symptoms in children and adolescents during COVID-19 in Australia. Australian & New Zealand Journal of Psychiatry. 2023;57(2):213-229. doi:10.1177/00048674221090174
Full text
Tesch F et al. Incident autoimmune diseases in association with a SARS-CoV-2 infection: A matched cohort study. medRxiv 2023.01.25.23285014; doi: https://doi.org/10.1101/2023.01.25.23285014
Full text
Wahlgren C et al. Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study. The Lancet. 2023 Feb 23. DOI:https://doi.org/10.1016/j.lanepe.2023.100595
Full text
Wang S et al. Adherence to healthy lifestyle prior to infection and risk of post–COVID-19 condition. JAMA Intern Med. Published online February 06, 2023. doi:10.1001/jamainternmed.2022.6555
Full text
Wang Z et al. The emerging antimicrobial resistance crisis during the COVID-19 surge in China. The Lancet. 2023 Feb 10. DOI:https://doi.org/10.1016/S2666-5247(23)00038-1
Full text
Wei Y et al. Estimation of vaccine effectiveness of CoronaVac and BNT162b2 against severe outcomes over time among patients with SARS-CoV-2 omicron. JAMA Netw Open. 2023;6(2):e2254777. doi:10.1001/jamanetworkopen.2022.54777
Full text
White BM et al. Exploring celebrity influence on public attitude towards the COVID-19 pandemic: social media shared sentiment analysis. BMJ Health & Care Informatics 2023;30:e100665. doi: 10.1136/bmjhci-2022-100665
Full text
Wong C et al. Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study. The Lancet. 2023 Feb 13. DOI:https://doi.org/10.1016/S1473-3099(22)00873-8
Full text
Wu N et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. The Lancet. 2023 Feb 10. DOI:https://doi.org/10.1016/S2213-2600(23)00015-2
Full text
Yip T et al. Impact of the use of oral antiviral agents on the risk of hospitalization in community coronavirus disease 2019 patients (COVID-19), Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e26–e33, https://doi.org/10.1093/cid/ciac687
Full text
Yue C et al. ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5. The Lancet. 2023 Feb 03. DOI:https://doi.org/10.1016/S1473-3099(23)00010-5
Full text
January 2023
Afroze F et al. Features and risk factors of post-COVID-19 syndrome: Findings from a longitudinal study in Bangladesh. The Lancet 2023 Jan 02. doi:https://doi.org/10.1016/j.lansea.2022.100134
Full text
Andersson N W et al. Comparative effectiveness of the bivalent BA.4-5 and BA.1 mRNA-booster vaccines in the Nordic countries. medRxiv 2023.01.19.23284764; doi: https://doi.org/10.1101/2023.01.19.23284764
Full text
Bobrovitz M et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.Lancet Infec Dis. 2023 Jan 18. doi:https://doi.org/10.1016/S1473-3099(22)00801-5
Full text
Cao Z et al. VV116 versus nirmatrelvir–ritonavir for oral treatment of Covid-19. NEJM. 2022 Dec 28. doi: 10.1056/NEJMoa2208822
Full text
Davis, H.E et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol (2023). https://doi.org/10.1038/s41579-022-00846-2
Full text
Ellis R J et al. Factors associated with hospitalisations and deaths of residential aged care residents with COVID‐19 during the Omicron (BA.1) wave in Queensland. MJA. 2023 Jan 23. doi: 10.5694/mja2.51813
Full text
Encinosa W et al. Complications, adverse drug events, high costs, and disparities in multisystem inflammatory syndrome in children vs COVID-19. JAMA Netw Open. 2023;6(1):e2244975. doi:10.1001/jamanetworkopen.2022.44975
Full text
Gottlieb M et al. Severe fatigue and persistent symptoms at three months following SARS-CoV-2 infections during the pre-delta, delta, and omicron time periods: A multicenter prospective cohort study, Clinical Infectious Diseases, 2023;, ciad045, https://doi.org/10.1093/cid/ciad045
Full text
Herman B et al. (2022) Post-COVID depression and its multiple factors, does Favipiravir have a protective effect? A longitudinal study of indonesia COVID-19 patients. PLoS ONE 17(12): e0279184. https://doi.org/10.1371/journal.pone.0279184
Full text
Hu S et al. Multidrug-resistant infection in COVID-19 patients: A meta-analysis. J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.10.043. Epub 2022 Nov 5. PMID: 36347426; PMCID: PMC9637013.
Full text
Huang NX et al. (2023) Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19. PLoS ONE 18(1): e0280280. https://doi.org/10.1371/journal.pone.0280280
Full text
Jang EJ et al. BNT162b2 vaccine effectiveness against the SARS-CoV-2 omicron variant in children aged 5 to 11 Years. JAMA Pediatr. Published online January 09, 2023. doi:10.1001/jamapediatrics.2022.5221
Abstract
Kamal A et al. Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial. BMC Infect Dis 23, 36 (2023). https://doi.org/10.1186/s12879-023-07993-8
Full text
Khoo W H et al Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19. Clinical Immunology. Vol 246, 2023 Jan. doi: https://doi.org/10.1016/j.clim.2022.109209.
Full text
Lee D et al. Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children. Science. 2022 Dec 20. doi/10.1126/science.abo3627
Full text
Malato J et al. Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months. The Lancet Infec Diseases. 2023 Jan 05. DOI:https://doi.org/10.1016/S1473-3099(22)00833-7
Full text
Massimo M et al. Haemorrhage of human foetal cortex associated with SARS-CoV-2 infection, Brain, 2023;, awac372, https://doi.org/10.1093/brain/awac372
Full text
McCarthy MW et al. Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: A randomized clinical trial. JAMA. 2023;329(4):296–305. doi:10.1001/jama.2022.24100
Full text
Mizrahi B et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 2023;380:e072529. doi: https://doi.org/10.1136/bmj-2022-072529
Full text
Nguyen TN et al. Global impact of the COVID-19 pandemic on stroke volumes and cerebrovascular events: A 1-year follow-up. Neurology. 2023 Jan 24;100(4):e408-e421. doi: 10.1212/WNL.0000000000201426. Epub 2022 Oct 18. PMID: 36257718.
Full text
Richard SA et al. Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw Open. 2023;6(1):e2251360. doi:10.1001/jamanetworkopen.2022.51360
Full text
Ronen A et al. Effectiveness of the bivalent mRNA vaccine in preventing severe COVID-19 outcomes: An observational cohort study. Available at SSRN: https://ssrn.com/abstract=4314067 or http://dx.doi.org/10.2139/ssrn.4314067
Full text
Schneider FH et al. Financial incentives for vaccination do not have negative unintended consequences. Nature 613, 526–533 (2023). https://doi.org/10.1038/s41586-022-05512-4
Full text
Senefeld JW et al. COVID-19 convalescent plasma for the treatment of immunocompromised patients: A systematic review and meta-analysis. JAMA Netw Open. 2023;6(1):e2250647. doi:10.1001/jamanetworkopen.2022.50647
Full text
Shi T et al. Dynamics of immune responses to inactivated COVID-19 vaccination over 8 months in China. Journal of Infection. 2023 Jan. doi:https://doi.org/10.1016/j.jinf.2022.08.041
Full text
Tang S et al. Education level modifies parental hesitancy about COVID-19 vaccinations for their children. Vaccine. 2023 Jan 9;41(2):496-503. doi: 10.1016/j.vaccine.2022.11.060. Epub 2022 Nov 29. PMID: 36494253; PMCID: PMC9705202.
Full text
Tao Ya-Chao et al. Mesenchymal stem cells therapy for COVID-19: from basic research to clinical trial, Current Stem Cell Research & Therapy 2023; 18() . https://dx.doi.org/10.2174/1574888X18666230118122256
Abstract
Tartof SY et al. Analysis of mRNA COVID-19 vaccine uptake among immunocompromised individuals in a large US health system. JAMA Netw Open. 2023;6(1):e2251833. doi:10.1001/jamanetworkopen.2022.51833
Full text
Tu WJ et al. Impact of the COVID-19 pandemic lockdown on hospitalizations for cerebrovascular disease and related in-hospital mortality in China: A nationwide observational study. Arch Gerontol Geriatr. 2023 Jan;104:104832. doi: 10.1016/j.archger.2022.104832. Epub 2022 Oct 4. PMID: 36219895; PMCID: PMC9531358.
Full text
Villar J et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. The Lancet. 2023 Jan 13. doi:https://doi.org/10.1016/S0140-6736(22)02467-9
Full text
Wan E W F et al. Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank, Cardiovascular Research, 2023;, cvac195, https://doi.org/10.1093/cvr/cvac195
Full text
Wang Y et al. The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination. J Infect Public Health. 2023 Jan;16(1):125-132. doi: 10.1016/j.jiph.2022.12.004. Epub 2022 Dec 6. PMID: 36516647; PMCID: PMC9724502.
Full text
Xiao H et al. Sex, racial, and ethnic representation in COVID-19 clinical trials: A systematic review and meta-analysis. JAMA Intern Med. 2023;183(1):50–60. doi:10.1001/jamainternmed.2022.5600
Full text
(Updated 7 May 2023)